Biotech · Private company
Oneness Biotech Co., Ltd.
Track this companyFree. Adds Oneness Biotech Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials92 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- Aquacel® Hydrofiber® dressingPhase 3 · Diabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- ON101 CreamPhase 3 · Chronic Diabetic Foot UlcersClinicalTrials.gov · fetched Nov 12, 2026
- ON101 CreamPhase 3 · Diabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle CreamPhase 3 · Chronic Diabetic Foot UlcersClinicalTrials.gov · fetched Nov 12, 2026
- FB825Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- MBS-COVPhase 2 · Mild to Moderate COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- FB825 in intravenous routePhase 1 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- MBS-COVPhase 1 · Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)ClinicalTrials.gov · fetched Nov 12, 2026
- Bonvadis® (NWBOT)Diabetic Foot Ulcers (DFUs)ClinicalTrials.gov · fetched Nov 12, 2026
- Clostridial Collagenase OintmentDiabetic Foot Ulcers (DFUs)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- PREPUP: A Randomized Trial of Bonvadis® Versus Collagenase Ointment in Diabetic Foot UlcersNA · NOT_YET_RECRUITING · started Aug 1, 2026ClinicalTrials.gov NCT07779239 · fetched Nov 12, 2026
- Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic DermatitisPHASE2 · RECRUITING · started Aug 8, 2024ClinicalTrials.gov NCT06397911 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 PatientsPHASE2 · COMPLETED · started Sep 11, 2023ClinicalTrials.gov NCT05941793 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy AdultsPHASE1 · UNKNOWN · started May 3, 2023ClinicalTrials.gov NCT05952986 · fetched Nov 12, 2026
- A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy ParticipantsPHASE1 · COMPLETED · started Nov 7, 2022ClinicalTrials.gov NCT05677893 · fetched Nov 12, 2026
- Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot UlcersPHASE3 · TERMINATED · started Jul 27, 2021ClinicalTrials.gov NCT04962139 · fetched Nov 12, 2026
- Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic DermatitisPHASE2 · UNKNOWN · started Mar 10, 2020ClinicalTrials.gov NCT04413942 · fetched Nov 12, 2026
- Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704APHASE1 · COMPLETED · started Mar 14, 2019ClinicalTrials.gov NCT03890302 · fetched Nov 12, 2026
- Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot UlcersPHASE3 · COMPLETED · started Nov 23, 2012ClinicalTrials.gov NCT01898923 · fetched Nov 12, 2026